Literature DB >> 9687426

Confirmatory evidence from 18S rRNA gene analysis for in vivo development of propamidine resistance in a temporal series of Acanthamoeba ocular isolates from a patient.

D R Ledee1, D V Seal, T J Byers.   

Abstract

DNA sequences of three 18S rRNA gene alleles present in trophozoites obtained before and after therapy for Acanthamoeba keratitis substantiate a previous report that the infection was due to a single Acanthamoeba strain. Thus, the possibility that propamidine resistance which developed during therapy was due to a mixed infection was ruled out.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9687426      PMCID： PMC105890     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

1.  Acanthamoeba keratitis--resistance to medical therapy.

Authors:  L Ficker; D Seal; D Warhurst; P Wright
Journal:  Eye (Lond)       Date:  1990       Impact factor: 3.775

2.  Differentiation of Acanthamoeba strains from infected corneas and the environment by using restriction endonuclease digestion of whole-cell DNA.

Authors:  S Kilvington; J R Beeching; D G White
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

3.  Mitochondrial DNA fingerprinting of Acanthamoeba spp. isolated from clinical and environmental sources.

Authors:  R K Gautom; S Lory; S Seyedirashti; D L Bergeron; T R Fritsche
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

4.  Acanthamoeba keratitis successfully treated medically.

Authors:  P Wright; D Warhurst; B R Jones
Journal:  Br J Ophthalmol       Date:  1985-10       Impact factor: 4.638

5.  Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine.

Authors:  D Seal; J Hay; C Kirkness; A Morrell; A Booth; A Tullo; A Ridgway; M Armstrong
Journal:  Eye (Lond)       Date:  1996       Impact factor: 3.775

6.  Restriction enzyme analysis of mitochondrial DNA of Acanthamoeba strains in Japan.

Authors:  K Yagita; T Endo
Journal:  J Protozool       Date:  1990 Nov-Dec

7.  Acanthamoeba griffini. Molecular characterization of a new corneal pathogen.

Authors:  D R Ledee; J Hay; T J Byers; D V Seal; C M Kirkness
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-03       Impact factor: 4.799

8.  Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy.

Authors:  J Hay; C M Kirkness; D V Seal; P Wright
Journal:  Eye (Lond)       Date:  1994       Impact factor: 3.775

9.  Diagnosis and successful medical treatment of Acanthamoeba keratitis.

Authors:  G D'Aversa; G A Stern; W T Driebe
Journal:  Arch Ophthalmol       Date:  1995-09

10.  The evolutionary history of the genus Acanthamoeba and the identification of eight new 18S rRNA gene sequence types.

Authors:  D R Stothard; J M Schroeder-Diedrich; M H Awwad; R J Gast; D R Ledee; S Rodriguez-Zaragoza; C L Dean; P A Fuerst; T J Byers
Journal:  J Eukaryot Microbiol       Date:  1998 Jan-Feb       Impact factor: 3.346
View more
  2 in total

1.  The identification of free-living environmental isolates of amoebae from Bulgaria.

Authors:  Nina Tsvetkova; Mark Schild; Stefan Panaiotov; Rossitza Kurdova-Mintcheva; Bruno Gottstein; Julia Walochnik; Horst Aspöck; Mar Siles Lucas; Norbert Müller
Journal:  Parasitol Res       Date:  2004-02-04       Impact factor: 2.289

2.  The differential expression of ribosomal 18S RNA paralog genes from the chaetognath Spadella cephaloptera.

Authors:  Roxane-Marie Barthélémy; Michel Grino; Pierre Pontarotti; Jean-Paul Casanova; Eric Faure
Journal:  Cell Mol Biol Lett       Date:  2007-06-24       Impact factor: 5.787
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.